Luye Pharma Group Ltd (LUP) — Capital Reinvestment Ratio
Luye Pharma Group Ltd (LUP) has a Capital Reinvestment Ratio of 1.01x as of June 2021, meaning it reinvests 1% of its operating cash flow (€274.59 Million) in capital expenditures (€278.10 Million). Check LUP tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Luye Pharma Group Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Luye Pharma Group Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Luye Pharma Group Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Luye Pharma Group Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Luye Pharma Group Ltd from 2016 to 2025. See LUP cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | €1.78 Billion | €1.00 Billion | ▼ -94.5% |
| 2024 | 10.18x | €167.76 Million | €1.71 Billion | ▲ +1294.4% |
| 2023 | 0.73x | €1.60 Billion | €1.17 Billion | ▲ +3.8% |
| 2022 | 0.70x | €1.65 Billion | €1.16 Billion | ▼ -76.9% |
| 2021 | 3.05x | €182.37 Million | €556.20 Million | ▲ +354.9% |
| 2020 | 0.67x | €1.03 Billion | €692.81 Million | ▼ -4.6% |
| 2019 | 0.70x | €1.42 Billion | €999.34 Million | ▲ +0.9% |
| 2018 | 0.70x | €1.05 Billion | €728.16 Million | ▲ +32.3% |
| 2017 | 0.53x | €964.10 Million | €507.32 Million | ▼ -2.4% |
| 2016 | 0.54x | €592.03 Million | €319.14 Million | — |